AKT1 and osteosarcoma: Functionally, ginsenoside Rh2 enhances apoptosis of U20S cells through increasing activity of MAPK pathway and suppressing activities of PI3K/AKT/mTOR and NF‐кB pathways in osteosarcoma cells (Fig. 3).